{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:59:49Z","timestamp":1790812789877,"version":"4.1.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"National Institute of Health","award":["U01AI069907"],"award-info":[{"award-number":["U01AI069907"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Chronic hepatitis C virus (HCV) infection contributes to substantial morbidity and mortality among adults living with HIV. Cascades of HCV care support monitoring of program performance, but data from Asia are limited. We assessed regional HCV coinfection and cascade outcomes among adults living with HIV in care from 2010\u20132020.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>Patients \u226518 years old with confirmed HIV infection on antiretroviral therapy (ART) at 11 clinical sites in Cambodia, China, India, Indonesia, South Korea, Thailand and Vietnam were included. HCV- and HIV-related treatment and laboratory data were collected from those with a positive HCV antibody (anti-HCV) test after January 2010. An HCV cascade was evaluated, including proportions positive for anti-HCV, tested for HCV RNA or HCV core antigen (HCVcAg), initiated on HCV treatment, and achieved sustained virologic response (SVR). Factors associated with screening uptake, treatment initiation, and treatment response were analyzed using Fine and Gray\u2019s competing risk regression model.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>Of 24,421 patients, 9169 (38%) had an anti-HCV test, and 971 (11%) had a positive result. The proportion with positive anti-HCV was 12.1% in 2010\u20132014, 3.9% in 2015\u20132017, and 3.8% in 2018\u20132020. From 2010 to 2014, 34% with positive anti-HCV had subsequent HCV RNA or HCVcAg testing, 66% initiated HCV treatment, and 83% achieved SVR. From 2015 to 2017, 69% with positive anti-HCV had subsequent HCV RNA or HCVcAg testing, 59% initiated HCV treatment, and 88% achieved SVR. From 2018 to 2020, 80% had subsequent HCV RNA or HCVcAg testing, 61% initiated HCV treatment, and 96% achieved SVR. Having chronic HCV in later calendar years and in high-income countries were associated with increased screening, treatment initiation or achieving SVR. Older age, injecting drug use HIV exposure, lower CD4 and higher HIV RNA were associated with reduced HCV screening or treatment initiation.<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusions<\/jats:title><jats:p>Our analysis identified persistent gaps in the HCV cascade of care, highlighting the need for focused efforts to strengthen chronic HCV screening, treatment initiation, and monitoring among adult PLHIV in the Asia region.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0287909","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T17:28:52Z","timestamp":1687973332000},"page":"e0287909","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3183-2451","authenticated-orcid":true,"given":"Jeremy","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanushi","family":"Rupasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Po","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagalingeswaran","family":"Kumarasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6975-057X","authenticated-orcid":true,"given":"Suwimon","family":"Khusuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vohith","family":"Khol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6339-3401","authenticated-orcid":true,"given":"I. Ketut","family":"Agus Somia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thach Ngoc","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasisopin","family":"Kiertiburanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2775-3315","authenticated-orcid":true,"given":"Jun Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuong","family":"Duy Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette H.","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awachana","family":"Jiamsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the TAHOD-LITE study group of IeDEA Asia\u2010Pacific","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"pone.0287909.ref001","author":"WHO","year":"2017","journal-title":"Global hepatitis report"},{"issue":"7","key":"pone.0287909.ref002","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis","volume":"16","author":"L Platt","year":"2016","journal-title":"The Lancet Infectious diseases"},{"key":"pone.0287909.ref003","author":"WHO","year":"2021","journal-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections"},{"key":"pone.0287909.ref004","doi-asserted-by":"crossref","first-page":"9241679","DOI":"10.1155\/2018\/9241679","article-title":"Epidemiological Profile and Risk Factors for Acquiring HBV and\/or HCV in HIV-Infected Population Groups in Nepal","volume":"2018","author":"M Bhattarai","year":"2018","journal-title":"Biomed Res Int"},{"issue":"73","key":"pone.0287909.ref005","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3126\/kumj.v19i1.49598","article-title":"Prevalence of Hepatitis B and C among HIV Infected Patients in Nepal over 1990\u20132020.","volume":"19","author":"DB Shrestha","year":"2021","journal-title":"Kathmandu Univ Med J (KUMJ)."},{"issue":"6","key":"pone.0287909.ref006","first-page":"950","article-title":"Hepatitis B and\/or C co-infection in HIV infected patients: a study in a tertiary care centre from South India","volume":"138","author":"N Chandra","year":"2013","journal-title":"Indian J Med Res"},{"issue":"5","key":"pone.0287909.ref007","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/MEG.0000000000000321","article-title":"Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam","volume":"27","author":"L Zhang","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"pone.0287909.ref008","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/2325957413500989","article-title":"Coinfection with hepatitis C virus among HIV-positive people in the Kathmandu Valley, Nepal","volume":"13","author":"KC Poudel","year":"2014","journal-title":"Journal of the International Association of Providers of AIDS Care"},{"issue":"1","key":"pone.0287909.ref009","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12879-022-07163-2","article-title":"Hepatitis C seroprevalence among people living with HIV\/AIDS and pregnant women in four provinces in Cambodia: an integrated bio-behavioral survey","volume":"22","author":"P Pheng","year":"2022","journal-title":"BMC infectious diseases"},{"issue":"2","key":"pone.0287909.ref010","first-page":"68","article-title":"Prevalence and Disease Burden of HCV Coinfection in HIV Cohorts in the Asia Pacific Region: A Systematic Review and Meta-Analysis","volume":"18","author":"M Martinello","year":"2016","journal-title":"AIDS Rev"},{"issue":"1","key":"pone.0287909.ref011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12985-020-01404-z","article-title":"Hepatitis B and hepatitis C prevalence among people living with HIV\/AIDS in China: a systematic review and Meta-analysis","volume":"17","author":"S Yu","year":"2020","journal-title":"Virol J"},{"issue":"1","key":"pone.0287909.ref012","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.7448\/IAS.19.1.20659","article-title":"Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study","volume":"19","author":"J Xie","year":"2016","journal-title":"Journal of the International AIDS Society"},{"issue":"3","key":"pone.0287909.ref013","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0049475513493416","article-title":"Prevalence of hepatitis C and B virus among patients infected with HIV: a cross-sectional analysis of a large HIV care programme in Myanmar","volume":"43","author":"SK Zaw","year":"2013","journal-title":"Trop Doct"},{"issue":"3","key":"pone.0287909.ref014","doi-asserted-by":"crossref","first-page":"e0194149","DOI":"10.1371\/journal.pone.0194149","article-title":"Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan","volume":"13","author":"CW Li","year":"2018","journal-title":"PloS one"},{"issue":"7","key":"pone.0287909.ref015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/23744235.2021.1898046","article-title":"High prevalence and genotype distribution of hepatitis C virus in people living with HIV in Kathmandu, Nepal","volume":"53","author":"KC Poudel","year":"2021","journal-title":"Infect Dis (Lond)."},{"issue":"4","key":"pone.0287909.ref016","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3904\/kjim.2015.353","article-title":"Incidence and risk factors of hepatitis C virus infection among human immunodeficiency virus (HIV) patients in a large HIV clinic in South Korea","volume":"31","author":"S Lee","year":"2016","journal-title":"Korean J Intern Med"},{"issue":"3","key":"pone.0287909.ref017","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1071\/SH20197","article-title":"Hepatitis C virus infection in HIV-infected men in Singapore, 2006\u20132018: incidence and associated factors.","volume":"18","author":"LW Ang","year":"2021","journal-title":"Sex Health."},{"issue":"9","key":"pone.0287909.ref018","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00705-020-04716-1","article-title":"Global prevalence of HCV and\/or HBV coinfections among people who inject drugs and female sex workers who live with HIV\/AIDS: a systematic review and meta-analysis","volume":"165","author":"R Rashti","year":"2020","journal-title":"Arch Virol"},{"issue":"1","key":"pone.0287909.ref019","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jmv.24912","article-title":"High prevalence of syphilis, HBV, and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital","volume":"90","author":"T Yang","year":"2018","journal-title":"J Med Virol"},{"issue":"2","key":"pone.0287909.ref020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s11904-014-0206-z","article-title":"Epidemiological implications of HIV-hepatitis C co-infection in South and Southeast Asia","volume":"11","author":"S Ye","year":"2014","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"8","key":"pone.0287909.ref021","doi-asserted-by":"crossref","first-page":"e0183530","DOI":"10.1371\/journal.pone.0183530","article-title":"A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.","volume":"12","author":"A De Weggheleire","year":"2017","journal-title":"PloS one"},{"issue":"1","key":"pone.0287909.ref022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40249-021-00921-5","article-title":"Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study.","volume":"11","author":"J Jia","year":"2022","journal-title":"Infect Dis Poverty"},{"issue":"11","key":"pone.0287909.ref023","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1473-3099(14)70946-6","article-title":"HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010\u201312: a retrospective observational cohort study","volume":"14","author":"F Zhang","year":"2014","journal-title":"The Lancet Infectious diseases"},{"issue":"2","key":"pone.0287909.ref024","doi-asserted-by":"crossref","first-page":"e88552","DOI":"10.1371\/journal.pone.0088552","article-title":"Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity","volume":"9","author":"J van Griensven","year":"2014","journal-title":"Cambodia. PloS one"},{"issue":"7","key":"pone.0287909.ref025","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/0956462416632428","article-title":"Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis","volume":"28","author":"M Farahani","year":"2017","journal-title":"International journal of STD & AIDS."},{"issue":"3","key":"pone.0287909.ref026","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/jvh.12630","article-title":"Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia","volume":"24","author":"N Durier","year":"2017","journal-title":"J Viral Hepat"},{"issue":"3","key":"pone.0287909.ref027","doi-asserted-by":"crossref","first-page":"e0150512","DOI":"10.1371\/journal.pone.0150512","article-title":"Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival","volume":"11","author":"M Chen","year":"2016","journal-title":"PloS one."},{"issue":"6","key":"pone.0287909.ref028","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jmv.23293","article-title":"Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients","volume":"84","author":"N Anggorowati","year":"2012","journal-title":"J Med Virol"},{"key":"pone.0287909.ref029","author":"WHO","year":"2018","journal-title":"Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection"},{"issue":"12","key":"pone.0287909.ref030","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/cid\/ciz714","article-title":"The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination","volume":"69","author":"K Safreed-Harmon","year":"2019","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America."},{"key":"pone.0287909.ref031","author":"WHO","year":"2016","journal-title":"Global health sector strategy on viral hepatitis 2016\u20132021"},{"key":"pone.0287909.ref032","article-title":"Viral hepatitis and the cascade of care among people living with HIV in the Asia-Pacific.","author":"D Rupasinghe","year":"2022","journal-title":"HIV medicine"},{"key":"pone.0287909.ref033","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jclinepi.2016.09.012","article-title":"A pseudo-random patient sampling method evaluated.","volume":"81","author":"NL De La Mata","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"pone.0287909.ref034","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1071\/SH16151","article-title":"Retrospective study of hepatitis C outcomes and treatment in HIV co-infected persons from the Australian HIV Observational Database.","volume":"14","author":"R Puhr","year":"2017","journal-title":"Sex Health."},{"issue":"3","key":"pone.0287909.ref035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/liv.13528","article-title":"Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study","volume":"38","author":"C Beguelin","year":"2018","journal-title":"Liver Int"},{"issue":"4","key":"pone.0287909.ref036","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jvh.13658","article-title":"Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study","volume":"29","author":"S Hosseini-Hooshyar","year":"2022","journal-title":"J Viral Hepat"},{"issue":"Suppl Suppl 2","key":"pone.0287909.ref037","doi-asserted-by":"crossref","first-page":"e25051","DOI":"10.1002\/jia2.25051","article-title":"Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era","volume":"21","author":"R Sacks-Davis","year":"2018","journal-title":"Journal of the International AIDS Society"},{"issue":"3","key":"pone.0287909.ref038","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/QAD.0000000000003112","article-title":"The hepatitis C cascade of care in HIV\/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences","volume":"36","author":"O Fursa","year":"2022","journal-title":"AIDS (London, England)"},{"key":"pone.0287909.ref039","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.puhe.2022.01.040","article-title":"The impact of COVID-19 pandemic on the 2020 hepatitis C cascade of care in the Republic of Georgia","volume":"205","author":"A Gamkrelidze","year":"2022","journal-title":"Public Health"},{"issue":"7","key":"pone.0287909.ref040","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4254\/wjh.v14.i7.1333","article-title":"Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings","volume":"14","author":"ZNA Said","year":"2022","journal-title":"World J Hepatol"},{"key":"pone.0287909.ref041","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijid.2021.02.068","article-title":"The hepatitis C cascade of care in the Belgian HIV population: One step closer to elimination","volume":"105","author":"D Busschots","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"7","key":"pone.0287909.ref042","doi-asserted-by":"crossref","first-page":"e102883","DOI":"10.1371\/journal.pone.0102883","article-title":"The hepatitis C cascade of care among HIV infected patients: a call to address ongoing barriers to care","volume":"9","author":"ER Cachay","year":"2014","journal-title":"PloS one"},{"issue":"12","key":"pone.0287909.ref043","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/infdis\/jiaa686","article-title":"Direct-Acting Antiviral Hepatitis C Treatment Cascade and Barriers to Treatment Initiation Among US Men and Women With and Without HIV","volume":"223","author":"DF Haley","year":"2021","journal-title":"The Journal of infectious diseases"},{"key":"pone.0287909.ref044","doi-asserted-by":"crossref","first-page":"726419","DOI":"10.3389\/fimmu.2021.726419","article-title":"A Tale of Two Viruses: Immunological Insights Into HCV\/HIV Coinfection.","volume":"12","author":"ST Gobran","year":"2021","journal-title":"Front Immunol."},{"issue":"9","key":"pone.0287909.ref045","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cix1004","article-title":"High Treatment Uptake in Human Immunodeficiency Virus\/Hepatitis C Virus-Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands","volume":"66","author":"A Boerekamps","year":"2018","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America."},{"issue":"22","key":"pone.0287909.ref046","article-title":"Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency Virus","volume":"19","author":"N Bar","year":"2022","journal-title":"International journal of environmental research and public health"},{"issue":"3","key":"pone.0287909.ref047","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1002\/hsr2.645","article-title":"Predictors of linkage to hepatitis C virus care among people living with HIV with hepatitis C infection and the impact of loss to HIV follow-up.","volume":"5","author":"AA Lau","year":"2022","journal-title":"Health Sci Rep"},{"issue":"1","key":"pone.0287909.ref048","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jvh.13405","article-title":"Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and\/or hepatitis B virus-co-infected patients in Myanmar","volume":"28","author":"Y Min Thaung","year":"2021","journal-title":"J Viral Hepat"},{"key":"pone.0287909.ref049","doi-asserted-by":"crossref","first-page":"103627","DOI":"10.1016\/j.drugpo.2022.103627","article-title":"Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.","volume":"103","author":"C Laniece Delaunay","year":"2022","journal-title":"Int J Drug Policy"},{"key":"pone.0287909.ref050","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/cid\/cit306","article-title":"Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis","volume":"572","author":"EJ Aspinall","year":"2013","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"5","key":"pone.0287909.ref051","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S2468-1253(21)00471-4","article-title":"Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis","volume":"7","author":"EB Cunningham","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"pone.0287909.ref052","doi-asserted-by":"crossref","first-page":"e25062","DOI":"10.1002\/jia2.25062","article-title":"Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it","volume":"212","author":"NK Martin","year":"2018","journal-title":"Journal of the International AIDS Society"},{"issue":"11","key":"pone.0287909.ref053","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1111\/liv.14983","article-title":"Outcomes of the CT2 study: A \u2019one-stop-shop\u2019 for community-based hepatitis C testing and treatment in Yangon, Myanmar","volume":"41","author":"BL Draper","year":"2021","journal-title":"Liver Int"},{"issue":"1","key":"pone.0287909.ref054","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3138\/canlivj-2021-0021","article-title":"Potential interventions to support HCV treatment uptake among HIV co-infected people in Canada: Perceptions of patients and health care providers","volume":"5","author":"D Ortiz-Paredes","year":"2022","journal-title":"Can Liver J"},{"issue":"6","key":"pone.0287909.ref055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/jvh.13268","article-title":"A same day \u2019test and treat\u2019 model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt.","volume":"27","author":"G Shiha","year":"2020","journal-title":"J Viral Hepat"},{"issue":"6","key":"pone.0287909.ref056","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1016\/S2352-3018(22)00077-7","article-title":"Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression","volume":"9","author":"S Hosseini-Hooshyar","year":"2022","journal-title":"The lancet HIV"},{"issue":"8","key":"pone.0287909.ref057","doi-asserted-by":"crossref","first-page":"ofac348","DOI":"10.1093\/ofid\/ofac348","article-title":"Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study.","volume":"9","author":"CH Liu","year":"2022","journal-title":"Open Forum Infect Dis."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0287909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T23:57:38Z","timestamp":1702684658000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0287909"}},"subtitle":[],"editor":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0287909","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]}}}